What is Mineralys Therapeutics, Inc.'s financing cash flow?

Mineralys Therapeutics, Inc. (MLYS) reported financing cash flow of $24.27M in Q1 2026.

How has Mineralys Therapeutics, Inc.'s financing cash flow changed year-over-year?

Mineralys Therapeutics, Inc.'s financing cash flow decreased by 87.2% year-over-year, from $189.28M to $24.27M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Mineralys Therapeutics, Inc. MLYS Financing Cash Flow

Financing Cash Flow at other companies

Aurinia PharmaceuticalsAUPH

-$53.69M-8.8%

Crinetics PharmaceuticalsCRNX

$389.88M+8,687%

Stoke Therapeutics, Inc.STOK

$84.33M+6,037%

ArriVent BioPharma, Inc.AVBP

$54.87M+712%

Kiniksa Pharmaceuticals International, plcKNSA

$6.07M+119%

CytokineticsCYTK

$7.77M+63.4%

Other financials

Income statement

See full

Operating income-$45.3M-2.0%

Net income-$39.3M+6.8%

EPS (diluted)-$0.47+40.5%

Balance sheet

See full

Cash & equivalents$1.2M-14.6%

Total equity$638.1M+86.8%

Total assets$652.9M+83.9%

Cash flow

See full

Operating cash flow-$39.5M+13.2%

CapEx$15.0K—

Free cash flow-$37.9M+43.3%

Valuation

See full

Market cap$2.27B+124%

Returns & leverage

See full

Return on equity-31%-9.6pp

Current ratio44.3×+17.8×

Where this comes from

Reported directly by Mineralys Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mineralys Therapeutics, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mineralys Therapeutics, Inc.'s financing cash flow?: Mineralys Therapeutics, Inc. (MLYS) reported financing cash flow of $24.27M in Q1 2026.
How has Mineralys Therapeutics, Inc.'s financing cash flow changed year-over-year?: Mineralys Therapeutics, Inc.'s financing cash flow decreased by 87.2% year-over-year, from $189.28M to $24.27M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.